Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-077447
Filing Date
2024-06-25
Accepted
2024-06-25 17:39:06
Documents
1
Period of Report
2024-06-21

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5696
  Complete submission text file 0000950170-24-077447.txt   7244
Mailing Address C/O UCSF, 1450 3RD STREET RM HD-371 SAN FRANCISCO CA 941439001
Business Address
MCCORMICK FRANK (Reporting) CIK: 0001257809 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 241070079

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)